Related Experiment Video
Updated: Jul 14, 2026
08:04
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
Identifying and validating novel targets with in vivo disease models: guidelines for study design
Hans-Joachim Anders1, Volker Vielhauer
1Medizinische Poliklinik, Universität München, Pettenkoferstrasse 8a, 80336 München, Germany. hjanders@med.uni-muenchen.de
Drug Discovery Today
|May 29, 2007
Summary
Inadequate study design compromises in vivo drug target identification and validation. Standardized criteria, similar to human trials, are essential for reproducible animal research and reliable drug development.
Area of Science:
- Pharmacology and Drug Discovery
- Translational Medicine
- Biomedical Research
Background:
- In vivo studies are crucial for identifying and validating novel drug targets.
- Current interpretation of in vivo data is often hindered by inadequate study design.
- Variability in protocols affects the reliability of target identification and validation.
Purpose of the Study:
- To highlight the importance of robust study design in in vivo target validation.
- To emphasize the need for species and target specificity in animal models.
- To advocate for standardized reporting criteria in preclinical studies.
Main Methods:
- Review of common study protocols in target identification and validation.
- Analysis of factors influencing data interpretation, including control groups and sample size.
- Examination of requirements for species and target specificity in animal models.
Main Results:
- Inadequate study design is a significant limitation in current in vivo research.
- Lack of clear rationale for species, strain, gender, and age selection impacts reproducibility.
- Discrepancies in study protocols complicate the validation of drug targets.
Conclusions:
- Standardized criteria, akin to those in human clinical trials, are necessary for in vivo target validation studies.
- Improved study design and reporting will enhance the reliability and reproducibility of preclinical drug discovery.
- Addressing these methodological issues is critical for advancing medicine through effective drug development.
Related Concept Videos
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...